New Panel-Agnostic Automated AML Diagnosis Solution Unveiled
A new diagnostic classification module for AHEAD Medicine’s Cyto-Copilot platform enhances AML versus non-neoplastic classification.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Flow Cytometry, Leukemia |
A new diagnostic classification module for AHEAD Medicine’s Cyto-Copilot platform enhances AML versus non-neoplastic classification.
Read MorePosted by Chris Wolski | Jul 4, 2024 | Sequencing Systems |
Whole genome sequencing has improved care for some children with cancer in England and can potentially replace multiple standard tests.
Read MorePosted by Chris Wolski | May 23, 2024 | Cancer |
Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.
Read MorePosted by Andy Lundin | Apr 30, 2024 | Leukemia, Molecular Diagnostics |
OGT launched a new next-generation sequencing (NGS) tool designed to identify key fusion genes associated with acute myeloid leukemia (AML).
Read MorePosted by Andy Lundin | Apr 17, 2024 | Cervical (HPV), Sequencing Systems, Urinalysis & Toxicology |
Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read More